Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. [electronic resource]
- Anticancer research
- 713-8 p. digital
Publication Type: Journal Article
0250-7005
Acyclovir--therapeutic use Adenoviridae--genetics Antiviral Agents--therapeutic use Cell Survival--drug effects Female Ganciclovir--therapeutic use Genetic Therapy Humans Ovarian Neoplasms--therapy Thymidine Kinase--genetics Tumor Cells, Cultured